Counterpulsation: A technique for assisting the circulation by decreasing the afterload of the left ventricle and augmenting the diastolic pressure. It may be achieved by intra-aortic balloon, or by implanting a special pumping device in the chest, or externally by applying a negative pressure to the lower extremities during cardiac systole.Intra-Aortic Balloon Pumping: Counterpulsation in which a pumping unit synchronized with the patient's electrocardiogram rapidly fills a balloon in the aorta with helium or carbon dioxide in early diastole and evacuates the balloon at the onset of systole. As the balloon inflates, it raises aortic diastolic pressure, and as it deflates, it lowers aortic systolic pressure. The result is a decrease in left ventricular work and increased myocardial and peripheral perfusion.Assisted Circulation: Pumping that aids the natural activity of the heart. (Dorland, 27th ed)Shock, Cardiogenic: Shock resulting from diminution of cardiac output in heart disease.Coronary-Subclavian Steal Syndrome: A complication of INTERNAL MAMMARY-CORONARY ARTERY ANASTOMOSIS whereby an occlusion or stenosis of the proximal SUBCLAVIAN ARTERY causes a reversal of the blood flow away from the CORONARY CIRCULATION, through the grafted INTERNAL MAMMARY ARTERY (internal thoracic artery), and back to the distal subclavian distribution.Angina Pectoris: The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.Heart-Assist Devices: Small pumps, often implantable, designed for temporarily assisting the heart, usually the LEFT VENTRICLE, to pump blood. They consist of a pumping chamber and a power source, which may be partially or totally external to the body and activated by electromagnetic motors.Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).Coronary Circulation: The circulation of blood through the CORONARY VESSELS of the HEART.Encyclopedias as Topic: Works containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. (From The ALA Glossary of Library and Information Science, 1983)Thigh: The portion of the leg in humans and other animals found between the HIP and KNEE.Tourniquets: Devices for the compression of a blood vessel by application around an extremity to control the circulation and prevent the flow of blood to or from the distal area. (From Dorland, 28th ed)Patents as Topic: Exclusive legal rights or privileges applied to inventions, plants, etc.OhioVentricular Function, Left: The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.Saudi ArabiaStroke: A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)Buttocks: Either of two fleshy protuberances at the lower posterior section of the trunk or HIP in humans and primate on which a person or animal sits, consisting of gluteal MUSCLES and fat.Brain Ischemia: Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION.Coronary Artery Bypass: Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion.Cardiac Surgical Procedures: Surgery performed on the heart.Cardiopulmonary Bypass: Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs.Patient Education HandoutRespiratory Rate: The number of times an organism breathes with the lungs (RESPIRATION) per unit time, usually per minute.Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.Bibliometrics: The use of statistical methods in the analysis of a body of literature to reveal the historical development of subject fields and patterns of authorship, publication, and use. Formerly called statistical bibliography. (from The ALA Glossary of Library and Information Science, 1983)Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).PhilippinesConsent Forms: Documents describing a medical treatment or research project, including proposed procedures, risks, and alternatives, that are to be signed by an individual, or the individual's proxy, to indicate his/her understanding of the document and a willingness to undergo the treatment or to participate in the research.Informed Consent: Voluntary authorization, by a patient or research subject, with full comprehension of the risks involved, for diagnostic or investigative procedures, and for medical and surgical treatment.Publishing: "The business or profession of the commercial production and issuance of literature" (Webster's 3d). It includes the publisher, publication processes, editing and editors. Production may be by conventional printing methods or by electronic publishing.Confidentiality: The privacy of information and its protection against unauthorized disclosure.Ventricular Dysfunction, Right: A condition in which the RIGHT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE or MYOCARDIAL INFARCTION, and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the right ventricular wall.Meningoencephalitis: An inflammatory process involving the brain (ENCEPHALITIS) and meninges (MENINGITIS), most often produced by pathogenic organisms which invade the central nervous system, and occasionally by toxins, autoimmune disorders, and other conditions.Catalogs, LibraryRegional Blood Flow: The flow of BLOOD through or around an organ or region of the body.Pulsatile Flow: Rhythmic, intermittent propagation of a fluid through a BLOOD VESSEL or piping system, in contrast to constant, smooth propagation, which produces laminar flow.Blood Flow Velocity: A value equal to the total volume flow divided by the cross-sectional area of the vascular bed.Exercise Test: Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used.Exercise Tolerance: The exercise capacity of an individual as measured by endurance (maximal exercise duration and/or maximal attained work load) during an EXERCISE TEST.Congresses as Topic: Conferences, conventions or formal meetings usually attended by delegates representing a special field of interest.Collateral Circulation: Maintenance of blood flow to an organ despite obstruction of a principal vessel. Blood flow is maintained through small vessels.Ambulatory Care: Health care services provided to patients on an ambulatory basis, rather than by admission to a hospital or other health care facility. The services may be a part of a hospital, augmenting its inpatient services, or may be provided at a free-standing facility.Pulmonary Embolism: Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.Hyperthyroidism: Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE.Heart: The hollow, muscular organ that maintains the circulation of the blood.Sleep: A readily reversible suspension of sensorimotor interaction with the environment, usually associated with recumbency and immobility.Myocytes, Cardiac: Striated muscle cells found in the heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC).Heart Rate: The number of times the HEART VENTRICLES contract per unit of time, usually per minute.

The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. (1/70)

OBJECTIVES: The purpose of this study was to assess safety and efficacy of enhanced external counterpulsation (EECP). BACKGROUND: Case series have shown that EECP can improve exercise tolerance, symptoms and myocardial perfusion in stable angina pectoris. METHODS: A multicenter, prospective, randomized, blinded, controlled trial was conducted in seven university hospitals in 139 outpatients with angina, documented coronary artery disease (CAD) and positive exercise treadmill test. Patients were given 35 h of active counterpulsation (active CP) or inactive counterpulsation (inactive CP) over a four- to seven-week period. Outcome measures were exercise duration and time to > or =1-mm ST-segment depression, average daily anginal attack count and nitroglycerin usage. RESULTS: Exercise duration increased in both groups, but the between-group difference was not significant (p > 0.3). Time to > or =1-mm ST-segment depression increased significantly from baseline in active CP compared with inactive CP (p = 0.01). More active-CP patients saw a decrease and fewer experienced an increase in angina episodes as compared with inactive-CP patients (p < 0.05). Nitroglycerin usage decreased in active CP but did not change in the inactive-CP group. The between-group difference was not significant (p > 0.7). CONCLUSIONS: Enhanced external counterpulsation reduces angina and extends time to exercise-induced ischemia in patients with symptomatic CAD. Treatment was relatively well tolerated and free of limiting side effects in most patients.  (+info)

Stabilisation of medically refractory ventricular arrhythmia by intra-aortic balloon counterpulsation. (2/70)

OBJECTIVE: To review the efficacy of intra-aortic balloon counterpulsation (IABCP) in medically refractory ventricular arrhythmia. DESIGN: Retrospective analysis of the outcome of patients with ventricular arrhythmia treated with IABCP after transfer between 1992 and 1997. SETTING: Tertiary cardiac referral centre. PATIENTS: 21 patients (mean age 58 years) who underwent IABCP for control of ventricular arrhythmia. All had significant left ventricular impairment (mean ejection fraction 28.6%); 18 had coronary artery disease. RESULTS: Before IABCP, 10 patients had incessant monomorphic ventricular tachycardia and 11 had paroxysmal ventricular tachycardia and/or ventricular fibrillation (VT/VF). IABCP resulted in suppression of ventricular arrhythmia in 18 patients, of whom 13 were weaned from IABCP. After stabilisation of ventricular arrhythmia, 10 patients were maintained on medical treatment alone and one underwent endocardial resection. IABCP was maintained until cardiac transplantation in five patients. One patient had a fatal arrest before discharge and one died from progressive heart failure. IABCP failed to control ventricular arrhythmia in three patients and was subsequently discontinued. A cardiac assist device was employed in one of these until cardiac transplantation; the other two were eventually stabilised on medical treatment. Nineteen patients were discharged from hospital. Overall survival was 95% at mean follow up of 25.7 months. CONCLUSIONS: IABCP can be an effective means of controlling refractory ventricular arrhythmia, allowing time for the institution of more definitive treatment.  (+info)

Improvement of regional myocardial and coronary blood flow reserve in a patient treated with enhanced external counterpulsation: evaluation by nitrogen-13 ammonia PET. (3/70)

Enhanced external counterpulsation (EECP) is a noninvasive treatment for chronic stable angina, which works by recruiting and developing the coronary collateral vessels. Coronary perfusion and coronary flow reserve (CFR) were evaluated by nitrogen-13 (13N) ammonia positron emission tomography (PET) in a patient who had undergone EECP. The patient, who had 3-vessel coronary artery disease, required a percutaneous transluminal coronary angioplasty (PTCA) for the right coronary artery. The PTCA was successful, but 6 months later he again felt chest oppression. The coronary angiography showed re-stenosis at the PTCA site, and other progressive coronary stenosis. The patient was again treated with EECP for 35 h. The 13N-ammonia PET was performed both at baseline and during dipyridamole provocation, before and after EECP treatment. Coronary perfusion of each myocardial wall increased at the baseline (anterior: 0.52-0.75; septal: 0.48-0.66; lateral: 0.61-0.68; inferior: 0.46-0.57 ml min(-1) g(-1), and the CFRs in the septal and inferior walls (septal: 2.07-2.15; inferior: 1.99-2.06) also increased after the treatment. Thus, the EECP treatment improved both coronary perfusion at baseline and CFR, which suggests that it may be one of the choices for treatment of angina.  (+info)

Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium. (4/70)

Cardiogenic shock developed in a 72-year-old Japanese woman during combination therapy with verapamil and atenolol for recurrent supraventricular arrhythmia. She had coronary atherosclerosis, liver cirrhosis and bradycardia-tachycardia syndrome. Despite of the high-dose catecholamines and counterpulsation, she progressively deteriorated. Bolus administration of intravenous calcium chloride (CaCl2) immediately resolved her hemodynamic collapse.  (+info)

Enhanced external counterpulsation improves exercise tolerance, reduces exercise-induced myocardial ischemia and improves left ventricular diastolic filling in patients with coronary artery disease. (5/70)

OBJECTIVES: We examined whether enhanced external counterpulsation (EECP) improves myocardial ischemia, exercise tolerance and cardiac function in patients with coronary artery disease (CAD). BACKGROUND: Enhanced external counterpulsation reduces angina and improves exercise tolerance in patients with CAD. Some objective improvements of ischemia by EECP have been reported, but they should be confirmed further. Detailed hemodynamic effects of EECP have been less well documented. METHODS: Enhanced external counterpulsation was performed for a total of 35 h in patients with stable CAD (n = 12) who showed evidence of exercise-induced myocardial ischemia despite conventional medical or surgical therapies. All patients had significant stenotic lesions in major coronary arteries. RESULTS: Enhanced external counterpulsation improved all exercise test parameters (p < 0.05): exercise duration, time to 1-mm ST segment depression, rate-pressure product at peak exercise and rate-pressure product at 1-mm ST segment depression. Moreover, the prevalence of exercise-induced reversible perfusion defects by thallium scintigraphy decreased after treatment (p < 0.01). Enhanced external counterpulsation did not alter systolic function but improved diastolic filling, left ventricular (LV) end-diastolic pressure (p < 0.05) by cardiac catheterization and LV peak filling rate end-diastolic volume/s (p < 0.01) and time to peak filling rate (p < 0.05) by radionuclide scintigraphy. These hemodynamic improvements were associated with decreased plasma brain natriuretic peptides levels after EECP (p < 0.05). CONCLUSIONS: Thus, EECP treatment improves exercise tolerance and reduced myocardial ischemia by thallium scintigraphy in association with improved LV diastolic filling in patients with stable CAD.  (+info)

Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by(13)N-ammonia positron emission tomography. (6/70)

AIMS: The mechanism by which enhanced external counterpulsation therapy exerts its beneficial effects on chronic and symptomatic stable angina is largely unknown. To clarify the mechanism of action of enhanced external counterpulsation, we used(13)N-ammonia positron emission tomography to evaluate myocardial perfusion. METHODS AND RESULTS: This was not a randomized controlled study. Eleven patients (eight male, age: 61.6+/-9.7) with angina pectoris underwent enhanced external counterpulsation therapy for 35 1 h sessions. They underwent a treadmill exercise test and(13)N-ammonia positron emission tomography, both at rest and with dipyridamole, before and after enhanced external counterpulsation therapy. Neurohumoral factors and nitric oxide were also evaluated. Myocardial perfusion increased at rest after therapy (0.69+/-0.27 to 0.85+/-0.47 ml x min(-1) x g(-1), P<0.05). In ischaemic regions, particularly the anterior region, myocardial perfusion at rest and with dipyridamole and coronary flow reserve improved significantly after therapy (at rest: 0.71+/-0.26 to 0.86+/-0.31;P<0.05, with dipyridamole: 1.26+/-0.65 to 1.84+/-0.94;P<0.02, coronary flow reserve: 1.75+/-0.24 to 2.08+/-0.28;P<0.04). Exercise time was prolonged and the time to 1-mm ST depression improved markedly (P<0.01). After therapy, nitric oxide levels increased (P<0.02) and neurohumoral factors decreased. CONCLUSIONS: Enhanced external counterpulsation therapy improved myocardial perfusion at rest and with dipyridamole and was associated with an increased exercise tolerance with(13)N-ammonia positron emission tomography and increased nitric oxide levels. These results suggest that one of the enhanced external counterpulsation mechanisms is development and recruitment of collateral vessels.  (+info)

Left ventricular systolic unloading and augmentation of intracoronary pressure and Doppler flow during enhanced external counterpulsation. (7/70)

BACKGROUND: Enhanced external counterpulsation (EECP) is a noninvasive, pneumatic technique that provides beneficial effects for patients with chronic, symptomatic angina pectoris. However, the physiological effects of EECP have not been studied directly. We examined intracoronary and left ventricular hemodynamics in the cardiac catheterization laboratory during EECP. METHODS AND RESULTS: Ten patients referred for diagnostic evaluation underwent left heart catheterization and coronary angiography from the radial artery. At baseline and then during EECP, central aortic pressure, intracoronary pressure, and intracoronary Doppler flow velocity were measured using a coronary catheter, a sensor-tipped high-fidelity pressure guidewire, and a Doppler flow guidewire, respectively. Similar to changes in aortic pressure, EECP resulted in a dramatic increase in diastolic (71+/-10 mm Hg at baseline to 137+/-21 mm Hg during EECP; +93%; P<0.0001) and mean intracoronary pressures (88+/-9 to 102+/-16 mm Hg; +16%; P=0.006) with a decrease in systolic pressure (116+/-20 to 99+/-26 mm Hg; -15%; P=0.002). The intracoronary Doppler measure of average peak velocity increased from 11+/-5 cm/s at baseline to 23+/-5 cm/s during EECP (+109%; P=0.001). The TIMI frame count, a quantitative angiographic measure of coronary flow, showed a 28% increase in coronary flow during EECP compared with baseline (P=0.001). CONCLUSIONS: EECP unequivocally and significantly increases diastolic and mean pressures and reduces systolic pressure in the central aorta and the coronary artery. Coronary artery flow, determined by both Doppler and angiographic techniques, is increased during EECP. The combined effects of systolic unloading and increased coronary perfusion pressure provide evidence that EECP may serve as a potential mechanical assist device.  (+info)

Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. (8/70)

OBJECTIVES: The goal of this study was to examine the effect of enhanced external counterpulsation (EECP) on endothelial function. BACKGROUND: Enhanced external counterpulsation improves symptoms and exercise tolerance in patients with symptomatic coronary artery disease (CAD). However, the exact mechanisms by which this technique exerts its clinical benefit are unclear. METHODS: Reactive hyperemia-peripheral arterial tonometry (RH-PAT), a noninvasive method to assess peripheral endothelial function by measuring reactive hyperemic response in the finger, was performed in 23 patients with refractory angina undergoing a 35-h course of EECP. In each patient RH-PAT measurements were performed before and after the first, at midcourse, and the last EECP session. In addition, RH-PAT response was assessed one month after completion of EECP therapy; RH-PAT index, a measure of reactive hyperemia, was calculated as the ratio of the digital pulse volume during reactive hyperemia divided by that at rest. RESULTS: Enhanced external counterpulsation led to symptomatic improvement (>/=1 Canadian Cardiovascular Society class) in 17 (74%) patients; EECP was associated with a significant immediate increase in average RH-PAT index after each treatment (p < 0.05). In addition, average RH-PAT index at one-month follow-up was significantly higher than that before EECP therapy (p < 0.05). When patients were divided by their clinical response, RH-PAT index at one-month follow-up increased only in those patients who experienced clinical benefit. CONCLUSIONS: Enhanced external counterpulsation enhances peripheral endothelial function with beneficial effects persisting at one-month follow-up in patients with a positive clinical response. This suggests that improvement in endothelial function may contribute to the clinical benefit of EECP in patients with symptomatic CAD.  (+info)

More than 6 million Americans suffer from angina, or chest pain, with as many as 350,000 new cases per year. As the group of people with heart disease increases, so does the group of patients who do not achieve complete relief of their angina despite current aggressive therapies, such as angioplasty and bypass surgery.. Our Cardiac Center offers external counterpulsation (ECP). This is a cardiac care therapy that provides relief from angina without surgery or medication. The treatment is designed to improve heart function by increasing blood flow to the heart muscle and decreasing the hearts workload. Basically, ECP improves the balance between the amount of oxygen the heart needs and the amount it receives.. External counterpulsation is a safe, well-tolerated procedure for treating angina with no significant side effect. Patients report:. ...
Hospitals, clinics and medical centers in Muntinlupa City, Philippines performing EECP treatment (Enhanced external counterpulsation).
April 2, 2009 - Vasomedical Inc. this week conducted two presentations on the beneficial effects of EECP external counterpulsation therapy at the 58th Annual Scientific Session of the American College of Cardiology (ACC) in Orlando.. The external EECP counterpulsation therapy is a noninvasive, outpatient therapy used in the treatment of ischemic cardiovascular diseases, currently used to manage chronic stable angina and heart failure. The therapy increases blood flow and oxygen supply to the heart muscle and other organs and decreases the hearts workload and need for oxygen. Function of the endothelium, the inner lining of blood vessels throughout the body, is also improved, lessening resistance to blood flow. These actions reduce or eliminate symptoms of angina and heart failure, the company said. The first presentation by Randy W. Braith, M.D., Richard C. Conti, M.D., and colleagues from the University of Florida in Gainesville demonstrated that EECP therapy significantly improves brachial ...
While an individual is undergoing ECP, he/she has pneumatic cuffs on his or her legs and is connected to telemetry monitors that monitor heart rate and rhythm. The most common type in use involves three cuffs placed on each leg (on the calves, the lower thighs, and the upper thighs (or buttock)). The cuffs are timed to inflate and deflate based on the individuals electrocardiogram. The cuffs should ideally inflate at the beginning of diastole and deflate at the beginning of systole. During the inflation portion of the cycle, the calf cuffs inflate first, then the lower thigh cuffs and finally the upper thigh cuffs. Inflation is controlled by a pressure monitor, and the cuffs are inflated to about 200 mmHg. ...
Hospitals, clinics and medical centers in Mandaluyong, Philippines performing EECP treatment (Enhanced external counterpulsation).
The results of the PEECH trial demonstrate that 35 1-h sessions of EECP over a period of 7 weeks benefited patients with mild-to-moderate HF and systolic LV dysfunction who were receiving PT. Enhanced external counterpulsation effected a statistically significant increase (p = 0.016) in the percentage of patients exceeding a 60-s improvement in exercise time, making this a positive trial based on the predefined statistical criteria for the primary end-point analysis. However, it must be noted that EECP did not alter the percentage of patients demonstrating an increase of ≥1.25 ml/kg/min in peak Vo2. Consistent with the improvement in the percentage of patients exceeding a 60-s improvement in exercise time, patients receiving active therapy also demonstrated a modest increase in exercise time when assessed as increase from baseline and an improvement in NYHA HF symptoms. These benefits of EECP were demonstrable after completion of EECP therapy as well as for up to 6 months. The active treatment ...
A stroke is usually caused by a blockage of one of the arteries that carries blood to the brain. Sometimes with a stroke, there may be a small amount of blood flow that manages to get through or around the blockage, and it may be possible that the amount of damage from a stroke may be reduced by increasing this blood flow. External counterpulsation (ECP) is a procedure in which a machine uses electrical signals from the heart that are detectable on the surface of the body in order to time the inflation of cuffs (similar to a blood pressure cuff) that are wrapped around a patients legs (calves, thighs and buttocks). Using a reading of the electrical activity from the patients heart (an electrocardiogram, or ECG, monitor), the machine inflates the cuffs with air at just the right time during each heart beat, during diastole, in order to change the blood pressure in a way that has been shown to increase blood flow to the kidneys, skin, eyes, heart, and brain.. In this study, patients presenting ...
Enhanced External Counterpulsation (EECP), therapy for persistant angina. Learn more about it from the nations top ranked heart center.
Learn more about Enhanced External Counterpulsation at Medical City Dallas DefinitionReasons for ProcedurePossible ComplicationsWhat to ExpectCall Your Doctorrevision ...
The cardiac assist device includes a sealed tubular housing for externally applying positive and negative relative pressure to a limb in counterpulsation with heart function. The applicator is assembled, in situ, to provide customized fit. It includes a fabric or sponge-like inner layer cut to size and situated around the limb. Initially deformable material is sized, sealed around the inner fabric layer and then secured by straps or the like to form a relatively rigid, non-expandable tubular shell. The shell may include an interior wall composed of a sheet of hard plastic or articulated sections of hard plastic or metal. The interior wall has a plurality of openings to the sealed shell interior. The exterior shell wall is positioned around the interior wall. The shell walls are spaced apart by radially and/or longitudinally extending spacer elements defining a multi-section air flow chamber between the walls. The interior shell wall and spacer elements may be integral. The spacer elements include
Researchers from Karolinska Institute in Stockholm, Sweden have just had their abstract entitled "Increases in Cardiac Output and Oxygen Consumption During Enhanced External Counterpulsation" published in Heart Lung Circulation. Heart Lung Circ. 2016 Nov;25(11):1133-1136. doi: 10.1016/j.hlc.2016.04.013. Epub 2016 May 18. Ahlbom M1, Hagerman I2, Ståhlberg M2, Manouras A2, Förstedt G3, Wu E3, Lund LH4. Author information Abstract BACKGROUND: Regular enhanced external counterpulsation (EECP) […]. ...
The patient is usually instructed to wear tight-fitting, seamless cycling pants or athletic tights to prevent chafing, one of the main adverse side effects. Before the procedure, the patients weight, blood pressure, pulse, and breathing rate are measured and recorded. The patients legs are examined for areas of redness and signs of potential vascular problems. The patient is asked to record his or her symptoms during the course of treatment to determine if and how symptoms improve over time. The patient should record the severity and duration of troublesome symptoms, the time the symptoms occurred, and any activities that may have triggered the symptoms. This patient record is reviewed before each treatment session. PATIENT EDUCATION. The health care team will ensure that the patient understands the potential benefits and risks of the procedure. Informative and instructional handouts are usually provided to explain the procedure. Because the procedure requires multiple outpatient visits ...
If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patients written consent to publication and send them to the editorial office before submitting your response [Patient consent forms] ...
Enhanced external counter pulsation is a process using cuffs to compress vessels in your lower limbs to increase blood flow. Learn more about EEC procedures here at Ohio State.
External Counterpulsation Therapy Mechanisms of Action. There is evidence demonstrating improved endothelial function via the hemodynamic effects by the increased shear stress acting on the arterial wall, reducing arterial stiffness and providing protective effects against inflammation, inhibiting intimal hyperplasia and the atherosclerotic process.. There is also evidence that ECP therapy triggers a neurohormonal response that induces the production of growth and vasodilatation factors, which together with the increased pressure gradient created across the occlusive site during ECP Therapy, promotes recruitment of new arteries, while dilating and normalizing the function of existing blood vessels. The collaterals bypass stenoses and increase blood flow to ischemic areas of the heart, leading to improved clinical outcomes.. ...
Intra-aortic balloon counterpulsation therapy has been the first-line strategy for patients requiring mechanical circulatory support for more than 40 years. No other percutaneous support device has proven superiority over IABPs for treating patients with acute coronary syndrome and other complications of heart failure.
For many patients, bypass surgery and stents have not relieved chest pain and other debilitating heart conditions. For some, another surgery is not an option; so many people continue to suffer with chest pain, congestive heart failure, or other heart related conditions. There is another alternative out there that may just be the answer. External counterpulsation therapy is a therapy that has been around for many years. ECP was approved by the FDA in the 1990s and was then approved in 1999 by Medicare. ECP is a safe alternative that is low risk and is a non-evasive procedure. ...
For many patients, bypass surgery and stents have not relieved chest pain and other debilitating heart conditions. For some, another surgery is not an option; so many people continue to suffer with chest pain, congestive heart failure, or other heart related conditions. There is another alternative out there that may just be the answer. External counterpulsation therapy is a therapy that has been around for many years. ECP was approved by the FDA in the 1990s and was then approved in 1999 by Medicare. ECP is a safe alternative that is low risk and is a non-evasive procedure. ...
Enhanced external counterpulsation therapy by its name itself signifies its extraordinary process. EECP is a non-invasive, non-surgical externally stimulated treatment that pulsates the nerves and increases the blood flow to the heart. Undoubtedly, the procedure takes few sessions, but nothing… Continue Reading →. ...
... Whitaker Wellness Institute is Americas largest alternative medicine clinic and wellness center.
Enhanced External Counterpulsation (EECP) is a nonsurgical treatment for angina (chronic chest pain) and other conditions involving poor circulation.
Counterpulsation methods and systems for assisting the heart of a patient involve, for example, coordinating the operation of a pulsatile pump to suction blood from an artery through a blood flow conduit while the heart is in systole and expel the blood into the blood flow conduit and the artery while the heart is in diastole.
They also suggest that coronary angiography may be helpful if initial stress testing is inconclusive or has conflicting results. In terms of SIHD treatment, the guideline writing group updated the recommendation for chelation therapy from "Class III: No Benefit" to "Class IIb" indicating the usefulness of chelation therapy is uncertain for reducing cardiovascular events in SIHD patients. "Although disodium ethylene diamine tetraacetic acid is approved by the U.S. Food and Drug Administration for specific indications, such as iron overload and lead poisoning, it is not approved for use in preventing or treating cardiovascular disease," they said. However, the writing group chose not to update the 2012 recommendation stating enhanced external counterpulsation (EECP) may be considered to help relieve refractory angina in SIHD patients. After re-examining the scientific evidence the group noted that, "in general, existing data, largely from uncontrolled studies, suggest a benefit from EECP among ...
Though coverage for congestive heart failure is not currently provided under Medicare, patients with stable congestive heart failure of ischemic etiology maybe covered under the aforementioned policy if they present with concomitant angina pectoris or angina equivalent symptoms as the primary diagnosis. The Centers for Medicare and Medicaid Services provide additional information on reimbursement. You can search for both national and local coverage decisions on the CMS website, including information on the national coverage decision (NCD) for external counterpulsation ...
TMR is a treatment aimed at improving blood flow to areas of the heart that were not treated by angioplasty or surgery. A special carbon dioxide (CO2) laser is used to create small channels in the heart muscle, improving blood flow in the heart. Frequently, it is performed with coronary artery bypass, occasionally alone.. For patients who have persistent angina symptoms and have exhausted the standard treatments without successful results, Enhanced External Counterpulsation (EECP) may stimulate the openings or formation of collaterals (small branches of blood vessels) to create a natural bypass around narrowed or blocked arteries. EECP is a non-invasive treatment for people who have chronic, stable angina; who are not receiving adequate relief from angina by taking nitrate medications; and who do not qualify for an invasive procedure such as bypass surgery, angioplasty or stenting.. For patients who have persistent angina symptoms and have exhausted the standard treatments without successful ...
Background: Emerging circulatory support devices that operate in counterpulsation to the native heart require synchronized timing of device ejection and filling on a beat-to-beat basis with the native heart using a patients ECG. Surface leads are commonly used for short-term patient monitoring but not appropriate for long-term use, and epicardial and non-thoracotomy leads increase the complexity of the device implant/explant procedures. Subcutaneous leads have been shown to be less susceptible to artifacts than surface leads, require less invasive surgery, and have recently been used successfully with a long-term subcutaneous implantable cardioverter-defibrillator. The objective of this study was to develop subcutaneous ECG leads for synchronized timing (filling and ejection cycles) of the Symphony device and wearable pneumatic driver for chronic counterpulsation therapy. To demonstrate feasibility, we tested the hypothesis that subcutaneous ECG leads provide equivalent QRS detection, lead migration,
EECP Treatment: EECP (enhanced external counter pulsation) therapy is an outpatient treatment used to improve blood circulation and increase cardiac output. It is normally used for angina and heart failure. In ME/CFS the treatment sessions are 30-45 minutes and are given once a week. During the treatment, the patient lies on a comfortable treatment table with large blood pressure-like cuffs wrapped around the legs and buttocks. These cuffs inflate and deflate continuously at specific times between heartbeats, a continuous electrocardiogram (EKG) set the timing so the cuffs inflate while the heart is at rest, in diastole, when it normally gets its supply of blood and oxygen. The cuffs deflate at the end of that rest period, just before the next heartbeat, systole. When timed correctly, this will decrease the afterload that the heart has to pump against, and increase the preload that fills the heart, increasing the cardiac output ...
Measurements and main results: Demographic, status discharge, EF, morbidity and use of resources were evaluated. Statistical analysis was performed with ANOVA of two ways and χ2. An excellent correlation between EF and mortality, reoperations, acute renal failure, multiorganic dysfunction, cardiorrespiratory arrest, and the use of Swanz-Ganz catheter, intra-aortic ballon counterpulsation, mechanical ventilation, dialysis and blood products was observed ...
Among these activities, coronary angioplasty in high-risk patients and those who have had an acute myocardial infarction is of particular importance. The interventional cardiologists of the Monzino Cardiology Centre have, in fact, gained recognised experience in the use of cardio-circulatory support techniques, such as aortic counterpulsation and percutaneous cardiopulmonary bypass, during percutaneous myocardial revascularization procedures in patients with compromised cardiac function.. The Unit also offers prompt availability of medical, nursing and technical staff, 24 hours a day, for primary coronary angioplasty in patients who arrive at the Monzino Cardiology Centre with an acute myocardial infarction. This intervention is now considered the best means of minimising functional damage to the heart pump and decreasing mortality in patients with heart attacks.. ...
Among these activities, coronary angioplasty in high-risk patients and those who have had an acute myocardial infarction is of particular importance. The interventional cardiologists of the Monzino Cardiology Centre have, in fact, gained recognised experience in the use of cardio-circulatory support techniques, such as aortic counterpulsation and percutaneous cardiopulmonary bypass, during percutaneous myocardial revascularization procedures in patients with compromised cardiac function.. The Unit also offers prompt availability of medical, nursing and technical staff, 24 hours a day, for primary coronary angioplasty in patients who arrive at the Monzino Cardiology Centre with an acute myocardial infarction. This intervention is now considered the best means of minimising functional damage to the heart pump and decreasing mortality in patients with heart attacks.. ...
EVIDENCE OF CLINICAL EFFICACY OF COUNTERPULSATION THEARPY METHODS Springer, December 2014 Abstract Although heart transplantation remains the ultimate treatment for end-stage heart failure, its epidemiological impact is limited by donor organ availability. Surgical and device-based approaches have been introduced with the aim of increasing systemic perfusion and in some circumstances promoting left ventricular recovery by […]. Read More. ...
Medical grade battery for DataScope - Mindray 95 Intra-Aorta Balloon Pump replaces manufacturer part 0146-00-0039. The output of this battery is 12.0V and the capacity is 18.0Ah. Batteryheads part LIF00928-1
Bauer (Sawyer), Patricia W. (Ph.D.). The Effects of Past Pregnancy Physical Activity Participation on Current Physical Activity, Barriers to Physical Activity, & Body Size, & the Validation of a Historical Physical Activity Recall Tool (Pivarnik). Colon, Geffrey (Ph.D.) Examination of Physical Education Teachers Perceived Preparation and Perceived Competence to Teach (Branta/Feltz). Coughlin, Adam (Ph.D.). Acute and Chronic Effects of Enhanced External Counterpulsation on Hemostatic Factors in CVD Patients (Womack). Dompier, Thomas P. (Ph.D). A Non-Invasive Method of Maturity Estimation and Intrinsic Risk Factors for Injury in Youth Football Players: Analysis of the 2002 and 2003 Seasons (Powell). Ferrara, Merissa (Ph.D.). The Effect of Self-Efficacy, Outcome Expectations, and Social Communication on Adherence to a Meal Replacement Program (Pivarnik). Learman, Jerome (Ph.D.). Comparison of Selected Kinesthetic Performance Variables from Two Different Weight Training Methods (Brown). Mackowiak, ...
There was no instant improvement in blood pressure or heart rate among sufferers in whom an intraaortic balloon pump was inserted, in comparison with those who didnt possess a balloon pump inserted. Although there is a positive aftereffect of intraaortic balloon counterpulsation on multiorgan dysfunction at day time 2 and day 3, as assessed with the use of the SAPS II, this impact had not been evident at day 4. There were also no significant results on C-reactive proteins level or serum lactate level, that have been assessed as measures of tissue and inflammation oxygenation. Experimental and clinical research have indicated that intraaortic balloon counterpulsation results in a hemodynamic benefit because of afterload reduction and diastolic augmentation with improvement in coronary perfusion.17 However, the consequences on cardiac output are modest and might not be sufficient to lessen mortality.17 In a recent, small, randomized trial, there were no significant variations in cardiac power ...
CRISP AMI: Intra-aortic Balloon Counterpulsation and Infarct Size in Patients with Acute Interior Myocardial Infarction Without Shock. -Trial Overview by Dr. Magnus Ohman and Dr. Manesh Patel (ESC 2011). IABP-SHOCK II: Randomized comparison of intra-aortic balloon counterpulsation versus optimal medical therapy in addition to early revascularization in acute myocardial infarction complicated by cardiogenic shock. -Trial Overview by Dr. Holger Thiele (ESC 2012). PROTECT II: Prospective Multicenter Randomized Trial Comparing IMPELLA to IABP in High Risk PCI. -90-Day Results by Dr. John Lasala (C3 Complex Intervention Meeting 2011) ...
Since the first description of the coronary collateral circulation in 1958,15 extensive investigations have been performed to elucidate the mechanisms that stimulate coronary collateral growth. Buschmann and colleagues16 were able to show a significant increase in collateral formation after 7 weeks of intermittent external counterpulsation in 23 patients with stable CAD in comparison with an inactive control group. An increase of collateral blood flow was detected by Zbinden in a nonrandomized clinical trial in 40 patients10 following regular physical exercise, performed 3 times a week over 3 months. However, PCI of the diseased vessel was performed before exercise training was initiated, which eliminated any possible ischemic trigger of collateral formation.. The underlying mechanism for increasing collateral blood flow has been the center of considerable debate.17 There are 2 distinct mechanisms that can be activated in the presence of ischemia caused by a flow-limiting lesion in an epicardial ...
Indications for use of the intraaortic balloon pump have expanded as advances in the treatment of heart disease have continued. The intraaortic balloon pump is the most widely used circulatory assist device inserted as short term or long term therapy
BACKGROUND AND OBJECTIVES: The use of IABP is helpful for haemodynamic stability of patients with low cardiac output and compromised left ventricular function in patients who undergo coronary artery bypass grafting. This procedure is also associated
kos″tŏ-kon-drīt′ĭs) [cost- + chondritis] Inflammation of the costochondral joints of the chest, which can cause chest pain. The pain of costochondritis can sometimes be distinguished from other, more serious forms of chest pain by its reproducibility on palpation of the involved joints and the absence of abnormalities on chest x-ray examinations, electrocardiograms, and blood tests. SYN: Tietze syndrome. SEE: arthritis. ...
TY - JOUR UR - http://lib.ugent.be/catalog/pug01:7037711 ID - pug01:7037711 LA - eng TI - Is there a place for intra-aortic balloon counterpulsation support in acute right ventricular failure by pressure-overload? PY - 2015 JO - (2015) INTERNATIONAL JOURNAL OF CARDIOLOGY SN - 0167-5273 PB - 2015 AU - Vanden Eynden, Frédéric GE10 000120959808 AU - Mets, Gilles AU - De Somer, Filip GE10 801002082325 0000-0001-7113-4565 AU - Bouchez, Stefaan 002005599884 AU - Bové, Thierry GE10 000080791094 ER ...
ABSTRACT. The mortality rate for cardiogenic shock has decreased over the past decade. These improvements are presumed to reflect increased use of intraaortic ballon counterpulsation and coronary reperfusion strategies which, by restoring patency to the infarct-related artery, can limit infarct size. Despite these therapeutic measures, mortality rates remain elevated. Current strategies are aimed at decreasing reperfusion times and measures to preserve and prolong myocardial cell viability. References. ...
Selfies are a fun way of taking in-the-moment shots, but they can also magnify what patients want to change about their appearance. Thats where noninvasive treatments can help.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies. ...
Introduction Angina pectoris is the most common symptomatic manifestation of ischaemic heart disease (IHD), and is usually caused by an imbalance between myocardial oxygen supply and demand. Standard therapy for angina pectoris includes pharmacological agents, such as rate-limiting drugs and vasodilators. When sym ...
This simple, effective angina treatment helps over 80% of patients resolve symptoms for 3-5 years with no drugs and no surgery required.
... High Intensity Focused Ultrasound is noninvasive treatment that kills prostate tissue with precision focused sound waves using MRI image guidance.
METHODS AND RESULTS Eighteen dogs were instrumented with regional myocardial function sonomicrometers in the ischemic and control zones. The left anterior descending coronary artery just distal to the first diagonal branch was instrumented with a silk snare and Doppler flow probe. Additionally, pressure catheters were placed in the left atrial appendage, left ventricular apex, and ascending aorta for hemodynamic measurements. Regional myocardial blood flow was determined by using 15-microns radioactive microspheres. Measurements were made in the control state, immediately after coronary occlusion, at 1 and 2 hours after coronary occlusion, with reperfusion, and 1 hour after reperfusion. In treated animals, left ventricular assistance was maintained during the entire period of occlusion and reperfusion. The Hemopump was associated with a significant decrease in left ventricular systolic and diastolic pressure, whereas mean arterial pressure was maintained. Intra-aortic balloon counterpulsation ...
Looking for online definition of c7E3 Fab Antiplatelt Therapy in Unstable Refractory Angina in the Medical Dictionary? c7E3 Fab Antiplatelt Therapy in Unstable Refractory Angina explanation free. What is c7E3 Fab Antiplatelt Therapy in Unstable Refractory Angina? Meaning of c7E3 Fab Antiplatelt Therapy in Unstable Refractory Angina medical term. What does c7E3 Fab Antiplatelt Therapy in Unstable Refractory Angina mean?
Arnica gels and ointments, omega-3 fatty acids from fish oil, borage oil, ginger, and green tea extract are noninvasive treatments for treating joint inflammation, according to WebMD. Curcumin or...
IN REPLY: Thanks to Dr. Wooltorton for a nice and optimistic overview of noninvasive treatments for umbilical granulomas. I would add a resource1 to his armamentarium that praises the curative effect of common salt on umbilical granuloma. This article1 states that the high concentration of sodium ion in the area draws water out of the cells and results in shrinkage and necrosis of the wet granulomatous tissue.. However, contrary to Dr. Wooltortons impression, we did not ignore the easily reversed root causes of these lesions; we mentioned them in the first two sentences of the abstract and the first part of the discussion of the article.2 Dr. Wooltorton also implies that our technique is only pertinent for small umbilical granulomas such as in the case we presented in our article.2 In reality, it is effective for large pedunculated granulomas and avoids a prolonged and usually unsuccessful trial of conservative treatment. In our experience of treating hundreds of umbilical granulomas in ...
Enhanced external counter-pulsation (EECP) therapy is helpful for some people who have Angina. Angina is chest pain or discomfort that occurs if an area of your heart muscle doesnt get enough oxygen-rich blood. EECP therapy improves the flow of oxygen-rich blood to your heart muscle and helps relieve angina. You typically get 35, 1-hour treatments over 7 weeks. Large cuffs, similar to blood pressure cuffs, are put on the legs. The cuffs are inflated and deflated in sync with your heartbeat. ...
HealthCosmos offers informative videos about all the aspects concerning chronic angina. Enter HealthCosmos and take part in our growing community.
This amazing article was written by Breanne Kallonen! We encourage you to check out her website and follow her on Facebook and Instagram!. Does your partners snoring keep you up at night? Or are you the culprit that is keeping them up?. Snoring is not only a nuisance; it can wreak havoc on your health. Research suggests that snoring, with or without sleep apnea, may increase your risk of cardiovascular disease (1). In fact, snoring may put you at more of a risk than being obese, smoking, or having high cholesterol(1)! The reason is there is an association between snoring and thickening of the lining of the carotid artery (2). Thickening of the carotid artery is problematic as it supplys oxygenated blood to the brain.. Snoring is a very real health concern that should be addressed. Noninvasive treatments that get to the cause should be considered when possible.. ...
SPECIAL FROM Grandparents.com With so much buzz about plastic surgery - both invasive and noninvasive treatments - its hard to know if any of them...
We explain conditions and disorders that are commonly treated using Gamma Knife PERFEXION™, the new standard in noninvasive treatment.
Two key news items in September made me think about the future direction of hemodynamic support, and that intra-aortic balloon pumps (IABP) will increasingly face a more serious challenge from small percutaneous left ventricular assist devices (pLVAD). This was reinforced when I received a cardiology market analysis from GlobalData agreeing with this assessment.. Since the 1970s, IABPs have been the gold standard for hemodynamic support in low ejection fraction patients, especially those with myocardial infarction complicated by cardiogenic shock. However, when IABPs were first introduced, there was no U.S. Food and Drug Administration (FDA) clinical trial requirement to prove efficacy. So, until now, only a few registry studies and clinical trials have shown IABPs can improve blood pressure and coronary perfusion. Based on this limited data, international guidelines recommend the use of IABPs for cardiogenic shock. Use of IABPs for cardiogenic shock is estimated at 25-40 percent of cases. This ...
[134 Pages Report] Check for Discount on Global Intra-aortic Balloon Pump (IABP) Market Status and Future Forecast 2015-2025 report by 99Strategy. Summary The Intra-aortic balloon pump (IABP) is a mechanical...
The bony thorax with its overlying muscles and integument creates a cage that protects the relatively fragile heart, great vessels, lungs, esophagus, and large lymphatic vessels. Disruption of the thorax by trauma, tumor, congenital anomaly, infection, or surgical intervention can have potentially lethal consequences. Advances in cardiac and thoracic surgery have enabled surgeons to operate safely within these cavities. Positive-pressure ventilation with the use of selective tubes and bronchial blockers permits surgeons to open the pleural spaces and continue respiration while the pleural cavity is disrupted. Technological advances in cardiac surgery include cardiopulmonary bypass, intraaortic balloon pumps, and ventricular assist devices that permit continued or augmented perfusion with oxygenated blood. These advances combined with a better understanding of biomaterials,1-3 tissue-engineered solutions, and advances in plastic and reconstructive surgery4-6 have permitted more complex sternal ...
Spanish investigators led by Drs. Eduardo Barge-Caballero and Marisa Crespo-Leiro from the Hospital Universitario A Coruña conducted a multi-institutional retrospective study of 704 patients with critical heart failure, who underwent urgent, high-priority heart transplantation in 15 Spanish hospitals from January, 2000 to December, 2009. One hundred and seven patients had been supported with short-term VADs before transplantation, while the remaining 597 had been bridged with conventional therapy, that included intravenous inotropes, invasive mechanical ventilation and / or intraaortic balloon pump. Implanted VADs were paracorporeal pulsatile-flow devices in 58 cases and extracorporeal continuous-flow ones in 47. Interestingly, mean waiting list time was extremely short, around 5 days, a characteristic fact of the well-organized Spanish high-emergency organ procurement and allocation system ...
In simple terms, refractory angina (RFA) is a disabling chronic heart pain, as a result of heart disease. Angioplasty, coronary artery bypass surgery, or even medical therapy have failed to control this chest pain. A chronic chest pain can be determined if it occurs longer than three months. The blockage of arteries takes place due to a build-up of plaque. As a result, blood flow slows down and makes it hard for oxygen-rich blood to reach the heart. This causes angina or chest pain. Those suffering from angina may experience back, neck, shoulder, arm, or jaw pain. Those with RFA have angina symptoms that are more severe and difficult to manage than those who experience regular stable angina. The symptoms are usually unmanageable; however, there are few specialized treatments that can aid in reducing the severity of the symptoms. A non-invasive therapy known as Enhanced External Counter Pulsation (EECP) places compressive cuffs on the upper and lower legs (calves, upper, and thighs). Along with ...
The Taipei Cancer Center said it is offering a new noninvasive treatment for bone metastasis that it said offers lasting pain relief without radiation.
Most noninvasive treatments stand no chance of providing a spinal stenosis cure, since narrowing of the central canal often needs to be unblocked surgically.
If age spots, stretch marks, or facial scarring have gotten you down, consider a noninvasive treatment that harnesses the power of both light and heat. It corre
Browse our extensive catalog of new & used Intra Aortic Balloon Pump Equipment for sale or auction. Find any required new, refurbished or used Intra Aortic Balloon Pump Equipment or device.
AMSTERDAM -- One year out, intra-aortic balloon pump (IABP) support still did not reduce mortality among patients with acute MI complicated by cardiogenic shock, extended follow-up of the IABP-SHOCK I
The Effect of Intraaortic Balloon Pumping Under Venoarterial Extracorporeal Membrane Oxygenation on Mortality of Cardiogenic Patients: An Analysis Using a Nationwide Inpatient Database http://journals.lww.com/ccmjournal/Fulltext/2016/11000/The_Effect_of_Intraaortic_Balloon_Pumping_Under.3.aspx
Results: The mean follow-up was 32.8±2.5 months. A standard 16-gene panel was performed in all patients. Fourteen patients (54%) were G+ve (4 MYBPC3, 3 M7H7 and 7 others). G+ve patients were more likely to be male (57%), younger (39 vs 66 years, p=0.0003) and have a family history of HCM (43 vs 8%, p=0.048). There was no difference in baseline diastolic septal diameter (G+ve 16.1±5.3 mm vs G-ve 17.4±7.3 mm, p=0.6) or ejection fraction (G+ve 64±2 % vs G-ve 63±2 %, p=0.697 ...
This CME accredited event will be held at the royal College of Physicians on Thursday 7th June 2007. For further information please contact 020 7935 1174 ext 252, [email protected] or visit the website. ...
The Canadian Cardiovascular Society Grading System for exertion-induced angina is used to gauge symptom severity. Grade I Grade I stable angina develops upon strenuous, rapid, and/or prolonged exertion during work or recreation but is not induced by ordinary physical activity, such as walking and climbing stairs.
An intra-aortic balloon pump includes a balloon, a catheter having a relatively small diameter lumen and an extender having a relatively large diameter lumen connected in series. A valve is positioned in the extender adjacent the end of the extender connected to the catheter. The valve enables the extender to be pressurized with a working gas prior to inflation of the balloon and to be evacuated prior to deflation of the balloon. A second valve adjacent the opposite end of the extender permits the intra-aortic balloon pump to commence a pre-inflation step or a pre-deflation step without affecting the pressure in the extender. Separate positive pressure and negative pressure extenders may be provided to reduce the movement of the working gas during inflation and deflation cycles, thereby increasing pneumatic efficiency.
The intra-aortic balloon pump, or simply IABP, is a catheterization procedure involving a balloon. The device is inserted into the aorta and is used to increase blood flow to the heart and reduce cardiac output. Although the procedure is sometimes elective, this may not be the case when it comes to a cardiac emergency. The IABP is most often used in individuals suffering from acute heart attack, heart failure and during certain kinds of heart surgery. Risks of having the balloon pump include, but are not limited to, infection, embolism and blockage of other arteries.
6.3 Japan Intra-aortic Balloon Pump (IABP) Sales Volume and Market Share by Type. About - Acute Market Reports :. Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the worlds most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.. Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.. Website : http://www.acutemarketreports.com. Browse All Reports of This Category - http://www.acutemarketreports.com/category/medical-equipments-market. Our Blog :- ...
Summarize the key concepts of the physiology behind and the rationale for hemodynamic support. Compare and contrast the various percutaneous hemodynamic support devices available. Describe the use of appropriate hemodynamic support devices based on the clinical scenarios including: complex high-risk PCI, CTO PCI, structural heart procedures and other novel settings. Describe the management of hemodynamic support devices in Cardiac Cath lab, Cardiovascular Intensive Care and other settings, including escalation and de-escalation of care, and access management.. ...
Pain Management, Psychologist, Peter R. Brown PhD, located in Orland Park, IL. Dr. Peter R. Brown is a pain psychologist. His practice is devoted to the noninvasive treatment of
During the first two years of life, the human body grows at an extremely rapid rate - Mehtas Growth Guidance Casting (MGGC) harnesses this vigorous natural growth as the corrective force and creates the possibility for young spines to grow straight three-dimensionally. Here are firsthand perspectives from children and families who have experienced MGGC. As youll see, casting is a process that can create a lifetime of health and well-being. The MGGC protocol, developed by orthopedic surgeon Min Mehta, MD, is a set of treatment principles that specifically adapts EDF Casting (extension, derotation and flexion) to treat infants and toddlers. It cannot be overstated that Early Detection and Early Treatment can dramatically lessen the number of casts required and the total time in casts. MGGC is the only gentle, noninvasive treatment for PIS.
Can you think back last fall and was there anything out of the ordinary that occurred? Did he have any vaccines before starting school? Was he sick with a flu, or did he take any medications that you can remember?How old is he? Has he been tested for Lymes? By Bowen or Igenex labs? Do you live in a Lyme infested area? I assume they tested him for B12 deficiency - make sure they did the best test they could and visit Sally Pacholoks thread on B12 misdiagnosis - this can cause severe neurological problems. I am so sorry for all you must be going through. I am sorry I cannot offer a diagnosis, I do want to suggest trying a treatment called NAET and see if it helps him. NAET is a noninvasive treatment that can help get the body back into balance. It is NOT a replacement for Western treatment or diagnosis. It can be an excellent supportive treatment, especially when allopathic medicine offers no good options. Best ...
A noninvasive treatment of multiple brain abscesses in the course of neonatal cerebrospinal meningitis with Proteus mirabilis as etiological agent - a case study ...
TY - JOUR. T1 - Protective antigen antibody augments hemodynamic support in anthrax lethal toxin shock in canines. AU - Barochia, Amisha V.. AU - Cui, Xizhong. AU - Sun, Junfeng. AU - Li, Yan. AU - Solomon, Steven B.. AU - Migone, Thi Sau. AU - Subramanian, G. Mani. AU - Bolmer, Sally D.. AU - Eichacker, Peter Q.. PY - 2012/3/1. Y1 - 2012/3/1. N2 - Background. Anthrax-associated shock is closely linked to lethal toxin (LT) release and is highly lethal despite conventional hemodynamic support. We investigated whether protective antigen-directed monoclonal antibody (PA-mAb) treatment further augments titrated hemodynamic support.Methods and Results.Forty sedated, mechanically ventilated, instrumented canines challenged with anthrax LT were assigned to no treatment (controls), hemodynamic support alone (protocol-titrated fluids and norepinephrine), PA-mAb alone (administered at start of LT infusion [0 hours] or 9 or 12 hours later), or both, and observed for 96 hours. Although all 8 controls died, ...
Persistence Market Research in its latest study on the global intra-aortic balloon pump market finds that factors such as high risk of infection and potential dangers of artery
Uterine fibroids often cause symptoms of pelvic pain, pressure, and bleeding. Traditional therapies have included medical (eg, hormonal therapy) and surgical (eg, myomectomy, hysterectomy) options. Recently, uterine artery embolization was added to the treatment armamentarium. We describe an exciting new non-invasive treatment option using focused ultrasound with magnetic resonance imaging and summarize the early experience at the Mayo Clinic in Rochester, Minn, during the initial research studies of this new technology ...
Missing data could be a source of uncontrolled bias. However, due to the low range of missing data in our data, it is unlikely to influence the results significantly. It is also important to note that patients who only received vasopressor therapy were completely excluded from the analysis. This is a unique population that may actually do better than patients represented in the current article. Despite these limitations, we believe the results show an underlying signal regarding the potentially harmful effect of perioperative inotropic therapy. Our results support the findings of two other important observational studies. Fellahi et al. reported that catecholamine administration was associated with major cardiac morbidity. In an initial cohort of 667 patients, perioperative use of catecholamines was associated with increased cardiac morbidity measured as a combined endpoint of postoperative sustained ventricular arrhythmia, need for an intraaortic balloon pump in ICU or postoperative MI. The ...
For ischemic heart disease with refractory angina that cannot be revascularized, Dr. Miller said options include optimizing medical therapy, such as beta-blockers, calcium channel blockers, nitrates, ranolazine, allopurinol, L-arginine, opioids, and perhaps some investigational agents (if you can get the patient enrolled in a clinical trial). In this setting, the heart team may include the patients general cardiologist, primary doctor, family, nurses, and perhaps other office staff.. While the medical record may suggest the patient is on appropriate therapy, adherence may be a factor. After MI, a large proportion of patients discontinue use of medications over time. Indeed, by 3 years, more than half of patients in one community-based study had already stopped taking statins, beta-blockers, or angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers.4. Also, its important to target risk factors through statin therapy, antihypertensives, antiplatelets, smoking cessation, weight ...
For the first time, researchers have employed local gene therapy to boost myocardial blood flow in areas that have impaired perfusion reserves. They have also determined that elevated plasma Lp(a) can serve as a biomarker to identify those individuals with refractory angina (RA) who can benefit from the experimental therapy, gene transfer of VEGF-DΔNΔC.
Datascope has received a complaint that has been associated with a patient death due to the failure of the device to initiate therapy.. This complaint involved a CS300 IABP that did not pump due to an electrical test failure code #58 (power up vent tests fail), maintenance code #3, and an autofill failure. An electrical test failure code #58 is caused by a solenoid valve requiring more power than the solenoid driver board can deliver to open the valve.. There are approximately 12,000 affected units sold globally. The affected IABP units were distributed in the U.S. and worldwide (in over 100 countries). Affected units were distributed between March 23, 2003, and December 11, 2013. Units distributed after December 11, 2013, are not affected by the field correction.. A service representative from Datascope will be replacing the defective solenoid driver boards. Customers having affected IABP unit(s) will be contacted by a representative of the Maquet/Getinge Service Team to schedule on-site ...
I have a question; how does one deal with the varying emotions of having both a Thoracic Aortic Aneurysm and chronic angina pain? Ive been on 60mg isosorbide mononitrate now for more than a month, ...
FUS is a noninvasive treatment method, as complete coagulation necrosis is achieved without the insertion of any instruments. However, FUS monitor has the poor visualization because of the presence of the multi-reflections, rib shadows and the emergence of the hyperecho after the FUS treatment. 3D Slicer imaging is a diagnostic imaging support system that can provide the same cross-sectional MPR images on the same monitor screen using DICOM volume data from MRI which are not influenced by those artifacts. The purpose of this study was to utilize an interventional navigation system designed for FUS assisted by 3D Slicer was proposed, and a phantom study was carried out to assess the proposed system. ...
Varicose veins are veins which appear bluish and swollen under the skin on your legs. These can be improved with noninvasive treatments from Dr. Walder.
Under the agreement, TFX will provide its complete lineup of Arrow Intra-Aortic Balloon Catheters and WAVE Intra-Aortic Balloon Pumps to more than 65,000 members served by Novation
2001 Canadian Cardiovascular Society Consensus Conference on Cardiac Transplantation, Ross H; Hendry P; Dipchand A; Giannetti N; Hirsch G; Issac D; et al. , Can J Cardiol, 2003, Volume 19, Issue 6, p.620-654, (2003) ...
2001 Canadian Cardiovascular Society Consensus Conference on Cardiac Transplantation, Ross H; Hendry P; Dipchand A; Giannetti N; Hirsch G; Issac D; et al. , Can J Cardiol, 2003, Volume 19, Issue 6, p.620-654, (2003) ...
'n Pasient met 'n siektegeskiedenis wat angina pectoris aandui, het by elektrokardiografiese ondersoek die bevinding van 'n positiewe inspanningstoets getoon.
Click the title to purchase the article.. Background:. "Femoral venoarterial extracorporeal membrane oxygenation (VA-ECMO) is widely used to maintain blood flow in patients with cardiogenic shock. However, retrograde blood flow increases left ventricular (LV) afterload during femoral VA-ECMO. Additional support by means of an intraaortic balloon pump (IABP) alleviates LV afterload but is associated with significant adverse events. We previously developed a system for rotational speed modulation in synchrony with the native cardiac cycle, for use with implantable continuous-flow LV assist devices. Here, we aimed to evaluate whether our novel rotation speed modulation system can improve coronary artery flow and reduce LV during femoral VA-ECMO."1. ...
University Centre Shrewsbury (UCS) staff, students and partners are kick-starting groundbreaking research and developing solutions to improve the health of people with heart, lung and circulation diseases.. Global company Renew Health is funding a project led by John Buckley, Professor of Applied Exercise Science at UCS and its Centre for Active Living. The investment is part of Renews Global Billions in Change movement which is tackling pressing problems around the world in the areas of water purification, accessible energy and preventative healthcare.. The initiative at UCS is investigating the benefits of External Counter Pulsation (ECP) Therapy, a treatment proven to improve peoples cardiovascular health. This includes people with heart disease who have not been able to have by-pass surgery or coronary angioplasty (stents) - a procedure used to widen blocked or narrowed arteries in the heart.. During Renew ECP treatment, inflatable cuffs (similar to blood pressure cuffs) are wrapped around ...
INTRODUCTION Stimulation of coronary collateral vessel growth by therapeutic angiogenesis (TA) offers an alternative treatment option for patients with refractory angina. Several TA modalities, including delivery to the heart of angiogenic growth factors (proteins or genes) and cells have been tested in clinical trials in the past two decades, but so far none of them resulted in significant therapeutic efficacy in large scale studies. This review attempts to identify the main obstacles hindering clinical success and recommends measures to overcome them in the future. AREAS COVERED After stating the medical need and rational for TA, and listing and briefly discussing past and current TA clinical trials, three main areas of obstacles are described: conceptual questions, technical limitations and clinical design uncertainties. Based on scientific and technical advances and lessons learned in past clinical trials, potential solutions to overcome some of these obstacles are proposed. EXPERT OPINION
Since the inception of the Canadian Cardiovascular Society heart failure (HF) guidelines in 2006, much has changed in the care for patients with HF. Over the past decade, the HF Guidelines Committee has published regular updates. However, because of the major changes that have occurred, the Guidelines Committee believes that a comprehensive reassessment of the HF management recommendations is presently needed, with a view to producing a full and complete set of updated guidelines. The primary and secondary Canadian Cardiovascular Society HF panel members as well as external experts have reviewed clinically relevant literature to provide guidance for the practicing clinician ...
Pet Laser Therapy- A surgery-free, drug-free, noninvasive treatment to: Reduce Pain and Inflammation Pet Allergies Speed Healing Deep Tissue Laser Therap...
Painful, bulging, and unsightly varicose veins often appear in the legs, ankles and feet. Get fast relief with noninvasive varicose vein treatment options at the Fairfax Vein Center. Call 703.698.4475 today to schedule a free screening appointment or a consultation with Virginias top vein doctors.
Levofloxacin price in pakistan / levofloxacin tablets ip 500mg used for / levofloxacin price costco / levaquin 500 mg iv : Your goal is a noninvasive treatment schedule or your hair or vocal chords.
The intra-aortic balloon pump (IABP) is a mechanical device that increases myocardial oxygen perfusion while at the same time increasing cardiac output. Increasing cardiac output increases coronary blood flow and therefore myocardial oxygen delivery. It consists of a cylindrical polyethylene balloon that sits in the aorta, approximately 2 centimeters (0.79 in) from the left subclavian artery and counterpulsates. That is, it actively deflates in systole, increasing forward blood flow by reducing afterload through a vacuum effect. It actively inflates in diastole, increasing blood flow to the coronary arteries via retrograde flow. These actions combine to decrease myocardial oxygen demand and increase myocardial oxygen supply. A computer-controlled mechanism inflates the balloon with helium from a cylinder during diastole, usually linked to either an electrocardiogram (ECG) or a pressure transducer at the distal tip of the catheter; some IABPs, such as the Datascope System 98XT, allow asynchronous ...
TY - JOUR. T1 - Femorofemoral bypass to relieve acute leg ischemia during intra-aortic balloon pump cardiac support. AU - Gold, Jeffrey P.. AU - Cohen, Jon. AU - Shemin, Richard J.. AU - DiSesa, Verdi J.. AU - Couch, Nathan. AU - Cohn, Lawrence H.. AU - Collins, John J.. AU - Mannick, John A.. AU - Whittemore, Anthony. PY - 1986/2. Y1 - 1986/2. N2 - This study reports our experience with 10 patients who underwent the emergent construction of a femorofemoral bypass graft to salvage an acutely ischemic lower extremity following the insertion of a transfemoral intra-aortic balloon pump catheter. All patients had excellent resolution of the ischemia and salvage of the extremity. Half of the procedures were done at the bedside with the remainder performed in the operating room. No long-term infections or ischemic sequelae resulted from the procedures in the nine patients available for long-term follow-up. The use of femorofemoral bypass grafting is, therefore, recommended in patients with severe ...
Angina pectoris is the medical term for chest pain caused by a lack of blood and/or oxygen in the heart muscle. The term comes from the Greek word "ankhon" meaning "strangling" and the Latin word "pectus" meaning "chest". This is most likely due to the fact that someone suffering from this condition describes the pain of an attack as a squeezing sensation, a tightness in the chest, or a feeling of pressure.. In addition to chest discomfort, pain from angina pectoris may also be felt in the upper abdomen, neck, jaw, back, or shoulders. The pain can be accompanied by sweating, breathlessness, or nausea. Angina pectoris attacks usually last for 1 to 5 minutes; pain lasting only a few seconds is normally not angina pectoris. Angina pectoris attacks that worsen as the attack progresses, angina pectoris that occurs suddenly while you are at rest, and angina pectoris lasting longer than 15 minutes are all considered signs of unstable angina. Unstable angina is an indication that an individual has a ...
Unstable angina pectoris benefits from counterpulsation. Post cardiothoracic surgery-most common and useful is counterpulsation ... Counterpulsation.htm Intra Aortic Balloon Pump (IABP) Counterpulsation by P. J Overwalder, M.D. "NewYork-Presbyterian Heart ' ... The first publication of intra-aortic balloon counter-pulsation appeared in the American Heart Journal of May 1962; 63: 669-675 ... allow asynchronous counterpulsation at a set rate, though this setting is rarely used. Helium is used because its low viscosity ...
... and enhanced external counterpulsation (EECP) for treatment of chest pain. In 2007, Lourdes began employing cool, pulsed laser ...
Intra-aortic balloon counter-pulsation. *Assessment of fluid requirement in critically ill patients *Hemorrhage ...
Enhanced external counterpulsation (EECP): Pneumatically assisting the heart to move blood using inflatable cuffs on the legs. ...
intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock " a meta-analysis of controlled trials". European ...
... counterpulsation technology. Datascope is a diversified cardiovascular device company that develops, manufactures and markets ...
Based on Kantrowitz's theory of "counterpulsation", the device inflated the balloon with helium gas when the heart relaxed and ...
Assessment of type of shock Assessment of therapy Afterload reduction Vasopressors Beta blockers Intra-aortic balloon counter-pulsation ...
... in which blood is treated with a photosensitizing agent and subsequently irradiated with light External counterpulsation, a non ...
Finding none of these approaches fully satisfactory, VASCOR has settled on a unique method for using a failsafe counter-pulsation ... Heilman and his Vascor coworkers expect to complete the development of a failsafe non-rotary implantable counterpulsation heart ...
... electrophysiology service Catheter ablation Pacemaker and defibrillator implants Enhanced external counterpulsation (EECP), the ...
... counterpulsation MeSH E04.050.215.400 --- intra-aortic balloon pumping MeSH E04.050.430 --- heart-assist devices MeSH E04.062. ...
... therapy (ECP) is a procedure that may be performed on individuals with angina, heart failure, or ... Lin, S; Liu, M; Wu, B; Hao, Z; Yang, J; Tao, W (18 January 2012). "External counterpulsation for acute ischaemic stroke". The ... Amin, F; Al Hajeri, A; Civelek, B; Fedorowicz, Z; Manzer, BM (17 February 2010). "Enhanced external counterpulsation for ... Manchanda A, Soran O (October 2007). "Enhanced external counterpulsation and future directions: step beyond medical management ...
External counterpulsation therapy (ECP) is a procedure that may be performed on individuals with angina, heart failure, or ... Lin, S; Liu, M; Wu, B; Hao, Z; Yang, J; Tao, W (18 January 2012). "External counterpulsation for acute ischaemic stroke". The ... Amin, F; Al Hajeri, A; Civelek, B; Fedorowicz, Z; Manzer, BM (17 February 2010). "Enhanced external counterpulsation for ... Manchanda A, Soran O (October 2007). "Enhanced external counterpulsation and future directions: step beyond medical management ...
Enhanced External Counterpulsation (EECP), therapy for persistant angina. Learn more about it from the nations top ranked ... Home / Health Library / Treatments & Procedures / Enhanced External Counterpulsation (EECP) Enhanced External Counterpulsation ... Enhanced External Counterpulsation (EECP) may stimulate the openings or formation of collaterals (small branches of blood ...
Learn more about Enhanced External Counterpulsation at Medical City Dallas DefinitionReasons for ProcedurePossible ... Enhanced external counterpulsation (EECP) is a treatment for chronic, stable chest pain known as angina . Angina happens when ... Enhanced external counterpulsation for chronic angina pectoris. Cochrane Database of Systematic Reviews. 2010;2:CD007219. ... Manchanda A, Soran O. Enhanced external counterpulsation and future directions: step beyond medical management for patients ...
External Counterpulsation More than 6 million Americans suffer from angina, or chest pain, with as many as 350,000 new cases ... External counterpulsation is a safe, well-tolerated procedure for treating angina with no significant side effect. Patients ... Our Cardiac Center offers external counterpulsation (ECP). This is a cardiac care therapy that provides relief from angina ...
External Counterpulsation. Counterpulsation, Diastolic. Ultrasonography, Doppler, Transcranial. Blood Flow Velocity. Neurologic ... External counterpulsation (ECP) is a procedure in which a machine uses electrical signals from the heart that are detectable on ... Safety Study of External Counterpulsation as a Treatment for Acute Ischemic Stroke (CUFFS). This study has been completed. ... The purpose of this study is to determine if external counterpulsation (ECP) is feasible to perform, tolerable, and safe as a ...
This leads to a counter pulsation of the blood. *When the heart contracts, the cuffs quickly deflate and relax. The sensation ... Enhanced external counterpulsation (EECP) is a procedure for the treatment of angina, heart failure or cardiomyopathy. It ... EECP (Enhanced External Counterpulsation) Treatment in Mandaluyong. Hospitals, clinics and medical centers in Mandaluyong, ...
enhanced external counterpulsation. HF. heart failure. LV. left ventricular. LVEF. left ventricular ejection fraction. MLWHF. ... 1974) External counterpulsation: Management of cardiogenic shock after myocardial infarction. JAMA 229:1441-1450. ... Enhanced external counterpulsation effected a statistically significant increase (p = 0.016) in the percentage of patients ... 2002) Enhanced external counterpulsation in patients with heart failure: a multicenter feasibility study. Congest Heart Fail 8: ...
The external EECP counterpulsation therapy is a noninvasive, outpatient therapy used in the treatment of ischemic ... this week conducted two presentations on the beneficial effects of EECP external counterpulsation therapy at the 58th Annual ... Results of Two Studies on Counterpulsation Therapy to Promote Collateral Growth Presented at the ACC ...
Aortic counterpulsation: A review of the hemodynamic effects and indications for use. Catheter Cardiovasc Interv 2006;67:68-77. ... Until recently, mechanical hemodynamic support was limited to the use of intra-aortic balloon pump (IABP) counterpulsation ...
Create healthcare diagrams like this example called Counterpulsation in minutes with SmartDraw. SmartDraw includes 1000s of ... Counterpulsation. Create healthcare diagrams like this example called Counterpulsation in minutes with SmartDraw. SmartDraw ... Counterpulsation. Image on left shows thorax with intra-aortic balloon catheter introduced via the femoral artery. Center image ...
... and left ventricular dysfunction respond very well to treatment using enhanced external counterpulsation (EECP), with little or ... and left ventricular dysfunction respond very well to treatment using enhanced external counterpulsation (EECP), with little or ...
External Counterpulsation (ECP) has improved the quality of their lives; it has allowed many to perform normal activities of ... External CounterPulsation (ECP) Centers,Looking for a way to help your patients with chronic angina or end stage cardiovascular ... External CounterPulsation (ECP) Centers. Features. ECP Clinical Benefits Clinical studies have shown that ECP treatment ... External Counterpulsation (ECP) has improved the quality of their lives; it has allowed many to perform normal activities of ...
... includes a sealed tubular housing for externally applying positive and negative relative pressure to a limb in counterpulsation ... High efficiency external counterpulsation apparatus and method for controlling same. USRE24357 *. Dec 18, 1953. Sep 17, 1957. ... 4. An external counterpulsation cardiac assist device for use on a body segment of a patient comprising means for receiving air ... External counterpulsation (ECP) device for use in an ambulance or the like for heart attack patients to limit heart muscle ...
... H. El-Halawany,1,2,3 A. Bajwa,1,2 M. Shobassy,1,2 A. ... Intra-aortic balloon pump counterpulsation (IABP) has been shown to prolong life in critically ill cardiac patients. However, ...
Enhanced external counterpulsation (EECP) is a treatment for chronic, stable chest pain known as angina. Angina happens when ... Enhanced external counterpulsation for chronic angina pectoris. Cochrane Database of Systematic Reviews. 2010;2:CD007219. ... Manchanda A, Soran O. Enhanced external counterpulsation and future directions: step beyond medical management for patients ... Enhanced external counterpulsation. Cleveland Clinic website. Available at: http://my.clevelandclinic.org/heart/disorders/cad/ ...
Care guide for Intra-aortic Balloon Counterpulsation Pump. Includes: possible causes, signs and symptoms, standard treatment ... What is an intra-aortic balloon counterpulsation pump?. An intra-aortic balloon counterpulsation pump (IABP) is a device that ...
Counterpulsation (IABP). Intra-aortic Balloon Counterpulsation therapies for the operating room or critical care enhance ... Counterpulsation Therapy: Should we continue to use it? * Treatment Strategies for the Complex Decompensated Heart Failure ... Web Seminar: Hemodynamics of Counterpulsation. The Intra-aortic balloon pump (IABP) has been the first-line choice for ... Assess the physiologic effects of Intraaortic Balloon Counterpulsation (IABP) therapy. *Understand the clinical utility of IAB ...
Intra-aortic balloon counterpulsation therapy has been the first-line strategy for patients requiring mechanical circulatory ... The purpose of this session is to share an experts experience on the use of counterpulsation therapy in the treatment of ... larger-capacity intra-aortic balloon counterpulsation pumps. The first reported patient comparison on 40cc vs. 50cc supports ...
Care guide for Intra-aortic Balloon Counterpulsation Pump (Discharge Care). Includes: possible causes, signs and symptoms, ... An intra-aortic balloon counterpulsation pump (IABP) is a device that is used for a short time to help your heart work normally ... Learn more about Intra-aortic Balloon Counterpulsation Pump (Discharge Care). Micromedex® Care Notes. *Intra-aortic Balloon ...
EECP is a safe, non-invasive outpatient treatment at Scripps for angina. Learn about EECP benefits, who is a candidate and what happens during treatment.
In another thread here, I mentioned the use of EECP, or Enhanced External Counterpulsation. This was recently mentioned at a Dr ... Enhanced External Counterpulsation (EECP) may stimulate the openings or formation of collaterals (small branches of blood ... HealingWell.com Forum , Diseases & Conditions , Heart & Cardiovascular Disease , EECP, or Enhanced External Counterpulsation ...
External Counterpulsation (ECP) is an ingenious method for treating angina that doesnt use drugs, is non-invasive, inexpensive ... The History of Counterpulsation. [Counterpulsation9]. Kantrowitz and Kantrowitz were the first to describe the principle of " ... 4One major company representing counterpulsation devices, Cardiomedics, uses the term ECP for external counterpulsation. See ... 3 This procedure is called either External Counterpulsation (ECP)4 or Enhanced External Counterpulsation (EECP)5 and has ...
The objective of this research was to study the vascular complications in patients with IABP counterpulsation. We observed the ...
A counterpulsation device that operates without the use of compressed air or pressurized gas includes at least one inflatable ... Unitary external counterpulsation device US20060058715A1 (en) * 2004-09-14. 2006-03-16. Hui John C. External counterpulsation ... Counterpulsation device using noncompressed air US10723070 US20040106885A1 (en) 1997-08-18. 2003-11-26. Counterpulsation device ... Counterpulsation device using noncompressed air US11050121 US20050137507A1 (en) 1997-08-18. 2005-02-03. Counterpulsation device ...
Enhanced External Counterpulsation (EECP). In Surviving with Heart: Taking Charge of Your Heart Care. Golden, CO: Fulcrum ... The concept of counterpulsation is not new (it was first introduced in the late 1950s at Harvard), but the computerized ... Enhanced External Counterpulsation in the Management of Patients with Cardiovascular Disease. Clinical Cardiology 22 (1999): ... Enhanced external counterpulsation (EECP) is a noninvasive procedure in which a set of inflatable cuffs (much like blood ...
  • Until recently, mechanical hemodynamic support was limited to the use of intra-aortic balloon pump (IABP) counterpulsation during percutaneous and surgical procedures or during recovery. (invasivecardiology.com)
  • Continuous flow (CF) left ventricular (LV) assist devices (LVAD) with LV or left atrial (LA) inlet, counterpulsation devices, percutaneous CF LVAD, and intra-aortic rotary blood pumps (IARBP) were quantified using established computer simulation and mock flow loop models. (deepdyve.com)
  • Counterpulsation provided greater coronary flow (CoF) augmentation, but had a lower reduction in LVEW compared to partial percutaneous LVAD support. (deepdyve.com)
  • Brodie BR, Stuckey TD, Hansen C, Muncy D. Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. (jamanetwork.com)
  • The cardiac assist device includes a sealed tubular housing for externally applying positive and negative relative pressure to a limb in counterpulsation with heart function. (google.com)
  • New results from a prospective, randomized, multi-center trial of the Impella CP heart pump (Abiomed) versus intra-aortic balloon (IAB) counterpulsation in patients with cardiogenic shock demonstrated no improvement in mortality with the Impella CP device and significantly more bleeding and hemolysis complications. (maquet.com)
  • Performance of a cardiac assist device pumping chamber in counterpulsation was evaluated using numerical simulations of the unsteady, three-dimensional flow inside the chamber and an analytical model of the force required to eject and fill the chamber. (asme.org)
  • The cuffs of counterpulsation bed adopt the Siamese-style design based on the curve of human body. (eecpmachine.com)